We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$791M
AUM Growth
+$12.6M
Cap. Flow
-$19.3M
Cap. Flow %
-2.44%
Top 10 Hldgs %
45.52%
Holding
139
New
7
Increased
27
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$11.1M
2
KEY icon
KeyCorp
KEY
+$3.27M
3
UPS icon
United Parcel Service
UPS
+$1.06M
4
SLB icon
SLB Ltd
SLB
+$915K
5
XOM icon
ExxonMobil
XOM
+$579K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.74M
2
JPM icon
JPMorgan Chase
JPM
+$9.72M
3
MET icon
MetLife
MET
+$6.47M
4
CB icon
Chubb
CB
+$4.94M
5
CVS icon
CVS Health
CVS
+$849K

Sector Composition

Rank Sector Weight
1 Financials 25.6%
2 Healthcare 19.03%
3 Technology 16.01%
4 Industrials 13.19%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
26
Fortive
FTV
$18.8B
$9.43M 1.19%
248,418
+793
+0.3% +$28.4K
JNJ icon
27
Johnson & Johnson
JNJ
$609B
$6.35M 0.8%
50,994
-220
-0.4% -$26.3K
AXS icon
28
AXIS Capital
AXS
$8.46B
$4.93M 0.62%
73,523
-1,548
-2% -$104K
UNH icon
29
UnitedHealth
UNH
$387B
$3.88M 0.49%
23,626
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$3.39M 0.43%
14,376
+915
+7% +$213K
KEY icon
31
KeyCorp
KEY
$25.4B
$3.18M 0.4%
+178,634
New +$3.27M
XOM icon
32
ExxonMobil
XOM
$611B
$2.99M 0.38%
36,405
+6,926
+23% +$579K
UNB icon
33
Union Bankshares
UNB
$117M
$2.62M 0.33%
61,032
-159
-0.3% -$6.67K
AON icon
34
Aon
AON
$78.4B
$2.2M 0.28%
18,541
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.06T
$2.15M 0.27%
12,924
ADNT icon
36
Adient
ADNT
$1.55B
$2.01M 0.25%
27,613
-307
-1% -$20.2K
BIIB icon
37
Biogen
BIIB
$30.4B
$1.95M 0.25%
7,115
KMI icon
38
Kinder Morgan
KMI
$71.9B
$1.87M 0.24%
85,932
-1,300
-1% -$28.4K
PG icon
39
Procter & Gamble
PG
$349B
$1.82M 0.23%
20,248
-490
-2% -$43.4K
WFC icon
40
Wells Fargo
WFC
$265B
$1.82M 0.23%
32,665
-2,237
-6% -$127K
TRMB icon
41
Trimble
TRMB
$12.3B
$1.67M 0.21%
52,000
MRK icon
42
Merck
MRK
$315B
$1.66M 0.21%
27,338
+692
+3% +$42K
IBB icon
43
iShares Biotechnology ETF
IBB
$9.23B
$1.48M 0.19%
15,174
+870
+6% +$83.3K
VEA icon
44
Vanguard FTSE Developed Markets ETF
VEA
$226B
$1.36M 0.17%
34,590
SBUX icon
45
Starbucks
SBUX
$120B
$1.29M 0.16%
22,049
+2,000
+10% +$113K
BRK.A icon
46
Berkshire Hathaway Class A
BRK.A
$1.06T
$1.25M 0.16%
5
IWF icon
47
iShares Russell 1000 Growth ETF
IWF
$123B
$1.21M 0.15%
42,560
+5,600
+15% +$155K
MMM icon
48
3M
MMM
$83.4B
$1.14M 0.14%
7,110
ADP icon
49
Automatic Data Processing
ADP
$102B
$1.13M 0.14%
11,068
+505
+5% +$51.5K
VDC icon
50
Vanguard Consumer Staples ETF
VDC
$7.96B
$1.12M 0.14%
7,972
+3,462
+77% +$480K

Similar funds

Cannell & Spears's Q1 2017 Portfolio in Review

As of Q1 2017, Cannell & Spears held 139 positions worth $791M, up 1.6% from $779M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cannell & Spears's Q1 2017 filing shows 7 new, 27 increased, 43 reduced and 7 closed positions. Its largest new stake was KeyCorp: 178,634 shares worth $3.18M. The largest sale was Thermo Fisher Scientific, an estimated $9.74M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.

  • Cannell & Spears's largest Q1 2017 buy was KeyCorp: 178,634 shares worth $3.18M.
  • Cannell & Spears added most to Gilead Sciences in Q1 2017, an estimated $11.1M increase.
  • Cannell & Spears's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $9.74M.
  • Cannell & Spears fully exited Kimberly-Clark in Q1 2017, selling an estimated $604K.
  • Cannell & Spears's ten largest holdings make up 46% of its $791M portfolio in Q1 2017.
  • Cannell & Spears opened 7 new positions and closed 7 in Q1 2017.
  • Cannell & Spears's portfolio value rose 1.6% quarter-over-quarter to $791M.

Based on Cannell & Spears's 13F filing for Q1 2017, filed 10 May 2017.